Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China
Mupadolimab clinical trial in China will be conducted by Angel Pharmaceuticals BURLINGAME, Calif., Sept. 26,…